PT-141
Melanocortin Receptor Agonist

Dosage
10mg
Unit Size
1 Vial
// Add to Cart
10mg
$40.00
99 in stock
What is PT-141?
PT-141 (bremelanotide) is a cyclic heptapeptide analogue of alpha-melanocyte stimulating hormone, engineered for greater stability and central nervous system access than the native hormone. Research interest centres on its activity at melanocortin receptors in the hypothalamus, where it is studied for effects on desire and arousal pathways rather than on blood flow.
MC4R
Primary Receptor Target
Cyclic
Peptide Structure
Central
Site of Action
Key Benefits
Central Pathway Activity
Studied for activation of hypothalamic melanocortin signalling rather than peripheral vascular effects.
MC4R Binding
Cyclic structure binds melanocortin-4 receptors with high affinity in preclinical receptor assays.
Dopaminergic Engagement
Downstream of MC4R, research models show engagement of dopamine-linked reward circuitry.
Stability Profile
The lactam ring bridges the peptide backbone, resisting enzymatic degradation better than linear analogues.
Desire Pathways
Investigated in models of hypoactive desire as a non-vascular mechanism of action.
Receptor Selectivity
Binding affinity across melanocortin receptor subtypes is a focal point of characterization work.
How It Works
Melanocortin Receptor Binding
PT-141 binds melanocortin receptor subtypes, with MC4R activity in the central nervous system considered the primary driver in published models.
Hypothalamic Signalling
Receptor activation in hypothalamic nuclei is studied as the entry point for downstream effects on arousal and desire pathways.
Dopamine Pathway Engagement
MC4R activation appears to recruit dopaminergic signalling, which researchers track as a marker of central pathway activity.
Cyclic Structure Advantage
The ring-closed backbone limits protease access, which is why the analogue reaches the CNS more reliably than linear MSH fragments.
Common Protocol (Research Reference)
1–2 mg
Study dose
Single dose
Administration model
Acute
Typical study design
Research Use Notice
PT-141 is a research peptide not approved by the FDA for human use. This information is for educational purposes only. Always consult a qualified healthcare professional before considering any peptide protocol.
